References

1. Dohner H, Estey E, Amadori S, et all. Diagnosis and managment of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European leukemiaNet. Blood. 2010; 115 (3):453-74. PubMed | Google Scholar


2. Tsieh S, Ernest W. Acute Monoblastic Leukemia With t(8;16):a Distinct Clinicopathologic Entity; Report of a Case and Review of the Literature. Am J Hematol. 2001; 66 (3):207?212. PubMed | Google Scholar


3. Heim S, Avanzi GC, Billstrom R et all. A new specific chromosomal rearrangement t(8,16)(p11,p13) in acute monocytic leukemia. Br J Haematol. 1987; 66 (3): 323-6. PubMed | Google Scholar


4. Haferlach T, Kohlmann A, Klein H et all. AML with translocation t(8;16)(p11;p13) demonstrates unique cytomorphological,cytogenetic, molecular and prognostic features .Leukemia. 2009; 23 (5): 934-943. PubMed | Google Scholar


5. Eva A, Coenen C, Michel Z, et all. Pediatric acute myeloid leukemia with t(8;16)(p11;p13), a distinct clinical and biological entity: a collaborative study by the International-Berlin-Frankfurt-Münster AML-study group. Blood. 2013; 122(15): 2704-2713. PubMed | Google Scholar


6. Paolo B, Ester O, Paola C. Translocation (8;16) in a patient with acute myelomonocytic leukemia occurring after treatment with fludarabine for a low-grade non-Hodgkin's lymphoma. Haematologica. 2000; 85 (10):1087-1091. PubMed | Google Scholar


7. Murati A, Adélaïde J, Quilichini B. New types of MYST3-CBP and CBP-MYST3 fusion transcripts in t(8;16)(p11;p13) acute myeloid Leukemias. Haematologica. 2007; 92 (2): 262-263. PubMed | Google Scholar